As I watch my wife, Audrey, navigate yet another day of unrelenting pain, I am reminded that the so-called “opioid crisis” peddled by policymakers and media headlines is a dangerous myth, one that has inflicted needless suffering on millions of chronic pain patients like her. At age 67, Audrey is a living testament to human resilience, enduring a litany of medical ordeals that would break most people. Yet, it’s not her illnesses that threaten her life the most; it’s the misguided Centers for Disease Control and Prevention (CDC) opioid guidelines that have turned compassionate care into a bureaucratic nightmare.
Drawing from the stark realities outlined in a recent article by Dr. Kayvan Haddadan’s on KevinMD.com (“How CDC opioid guidelines harmed chronic pain patients,” April 18, 2026), it is clear that these guidelines, far from saving lives, have irreparably harmed the very patients they were meant to protect. Audrey’s story isn’t just personal. It’s a demand for reform, proving that the true crisis isn’t prescription opioids, but illicit fentanyl, and that denying pain relief to those who need it is outrageous cruelty.
Audrey’s journey began at age 28 with a hysterectomy, a procedure that upended her life and introduced her to the world of chronic pain. What followed was a cascade of diagnoses: fibromyalgia and myofascial pain syndrome, conditions that turned every movement into agony. By 48, both her knees had been replaced, restoring her mobility and increasing her quality of life, but at great cost. At 55, she underwent major surgery to restore lung function. Doctors removed a rib and sewed her trachea to her interior muscle walls, a grueling intervention that left her scarred but breathing. Add to that an oophorectomy, gall bladder removal, a broken back at 63 that left her bedridden for months, and metaplastic breast cancer at 65. This history has generated a portrait of a woman who has stared down more physical torment than most could imagine.
Through it all, Audrey has depended on a carefully managed regimen of opioid pain medication, 90 mg per day, as well as Lyrica and Savella, prescribed by her competent general practitioner. These medications aren’t luxuries; they’re lifelines that allow her to function, to laugh with our grandchildren, to find joy in small moments.
Addiction? It’s not even a minor consideration for legitimate pain patients. Dr. Haddadan correctly clarifies, based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), that dependence and tolerance are normal physiological responses to pain treatment, not signs of addiction. For patients like Audrey, under close medical supervision, the risk of treatment-related abuse is minuscule. Studies cited in the article peg it at one to three patients per 1,000. Pain control and quality of life are the only priorities.
Without these medications, tailored to her specific needs, Audrey would be dead. Many in her position have chosen suicide rather than face the overwhelming pain and loss of function. But Audrey meets each day with faith, optimism, and fortitude, a quiet heroism that shames the fearmongers who paint all opioid use with the tarred brush of addiction.
The 2016 CDC Guideline for Prescribing Opioids for Chronic Pain, aggressively pushed by recovery industry hacks like former U.S. Department of Health and Human Services (HHS) Secretary Tom Price and CDC Director Tom Frieden, was supposed to curb overdoses. Instead, as Dr. Haddadan’s analysis points out, it triggered widespread suffering among legitimate patients while ignoring the real culprit: illicit fentanyl. CDC guidelines were predictably misapplied as rigid mandates, leading to sharp reductions in prescribing that didn’t reduce overdoses. In fact, they drove desperate patients to deadlier street drugs.
Since 2012, opioid prescriptions have plummeted over 52 percent, from 260.5 million to 125.7 million by 2024, with total Morphine Milligram Equivalent (MME) dosages down 65 percent. Yet overdose deaths surged, almost entirely due to illicit synthetics. Provisional data from 2025 shows a 25 percent drop in overdoses, but that outcome is thanks to harm reduction, naloxone access, and treatment expansion, not further cuts to prescriptions. Only 1.3 percent of recent overdose victims had an active legitimate prescription.
Audrey’s doctor, a trusted general practitioner, understands the realities of pain practice. He prescribes based on her needs, not arbitrary MME thresholds that lack robust scientific grounding. But the guidelines’ legacy has created a chilling effect. Public officials like Senators Bill Cassidy, Mike Crapo, and Ron Wyden have acknowledged how the 2016 and even the 2022 guidelines were misinterpreted as inflexible rules, leading to forced tapering or abandonment of stable patients. For Audrey, any hint of such interference could be catastrophic.
A 2022 CDC update admitted these failures, stressing that recommendations should be flexible and individualized, not blunt instruments wielded by insurers, pharmacies, or regulators. Yet, both CDC versions encouraged abrupt tapers, underweighting patients’ needs and overemphasizing misuse risks. This has produced undertreatment, psychological distress, illicit drug substitution, overdoses, and suicides, a “silent public health crisis,” as described by Human Rights Watch, the American Medical Association (AMA), and patient advocates.
Consider the human toll. A 2023 UC Davis study of over 110,000 stable long-term opioid patients found that tapering led to more emergency visits, hospitalizations, reduced primary care engagement, and poorer adherence to other medications. Tapering has led to suicide in multiple documented cases. The AMA’s 2025 report reinforces that individualized care, not arbitrary restrictions, must guide decisions. Forced tapers have tripled overdose risks and increased suicides, eroding trust in health care.
At the SYNC-2026 harms reduction conference in March 2026, experts called out the 2016 guidelines as politically driven and riddled with methodological errors. A 2024 STAT analysis and a 2025 Lancet study confirm that the crisis is multifactorial, rooted in social conditions, limited addiction treatment, and illicit fentanyl saturation, not “overprescribing” by doctors.
Audrey’s story personalizes these statistics. Her pain isn’t abstract; fibromyalgia flares that leave her immobilized. Post-knee-replacement aches make stairs a battle, and lingering effects of her lung surgery turn breathing into labor. Opioids, combined with Lyrica for nerve pain and Savella for fibromyalgia, give her the ability to engage with life. Deny her that, and you’re not preventing addiction. You’re condemning her to a hellish existence.
Mental health history is far more predictive of overdose or suicide than opioid prescriptions themselves. Audrey’s optimism and faith sustain her, but without proper pain management, even that might not be enough. Dr. Haddadan’s call for evidence-based care resonates deeply: Protect stable patients from forced tapers, reject MME mythology, expand non-opioid therapies without barriers, and target the illicit supply.
This issue isn’t just about Audrey; it’s about millions suffering in silence. The opioid crisis is an illegal fentanyl crisis, not a prescription issue. Blaming clinicians and patients ignores the data. Policymakers must heed the CDC’s own admissions and redirect resources toward harm reduction and addiction treatment, not punitive restrictions.
As a 2024 analysis noted, massive prescribing reductions failed because they addressed the wrong problem. For Audrey, every day is a victory against overwhelming odds. Should Audrey’s wonderful doctor suddenly die or move, there is no one to replace him. So-called “pain clinics” are too often cynical “trains to Auschwitz,” funneling people with pain into ineffective, expensive, “alternative pain treatment” mills that provide little to no relief for anyone. How many more must be condemned to endure forced tapering, untreated pain, or worse before we prioritize compassion over hysteria?
It’s time for decisive action. Insurers and regulators must stop treating guidelines as mandates. Doctors like Audrey’s GP need the freedom to provide patient-centered care without fear. And society must recognize that for chronic pain sufferers, opioids aren’t the enemy. They’re often the difference between life and death. Audrey’s fortitude inspires me, but it shouldn’t have to. Let’s reform these harmful policies before more lives are lost to bad policies and fake data.
Frank Carroll is a patient advocate.
